OBJECTIVES: To determine prevalence and correlates of Human Papillomavirus (HPV) vaccination in adolescent girls who were recommended to receive vaccine by their healthcare providers. METHODS: A retrospective cross-sectional analysis involving adolescent girls (11-17 years) was conducted using the 2007 National Survey of Children’s Health (NSCH). The analysis focused on adolescent girls who were recommended to receive HPV vaccine. Descriptive weighted statistics was used to examine prevalence of HPV vaccination. Multivariate logistic regression within the conceptual framework of Andersen Behavioral Model was used to examine the correlates of HPV vaccination in this at-risk population. RESULTS: Of 14.43 million adolescent girls in the United States, 3.69 million or 25.54 % (95% Confidence Interval [CI], 24.02-27.06) were recommended to receive the HPV vaccine by their healthcare provider. Amongst those who were recommended, only 48.75% (95% CI, 45.37-52.13) received the HPV vaccine. The majority who received the HPV vaccine were in the 13 – 17 age groups (82.67%), white (66.94%), and non-Hispanic (84.83%).  Multivariate logistic regression revealed that enabling (socioeconomic status) and predisposing (number of adults in the household and preventive medical care visit) factors were significantly associated with the HPV vaccination. Children living at 100-200% of the Federal Poverty Level (FPL) (Odds Ratio [OR] 0.54, 95% CI 0.30-0.98) were less likely to receive the vaccine than those living below 100% of the FPL. Children in households with two or more adults (OR 0.51, 95% CI, 0.33-0.80) were negatively associated and those with any previous preventive medical care visit (OR 2.28, 95% CI, 1.36-3.84) were positively associated with HPV vaccination. CONCLUSIONS: Less than half of the girls received HPV vaccine among those who were recommended by their healthcare provider. The study finding emphasizes importance of predisposing and enabling factors for HPV vaccination.  Policy and educational efforts can focus on these factors to improve HPV vaccination rates.